Mary Norine Walsh, MD
September 29th, 2014
The Implications of PARADIGM-HF for Clinical Practice
Clyde Yancy, MD and Mary Norine Walsh, MD
Clyde Yancy and Mary Norine Walsh offer their perspectives on the much-discussed PARADIGM-HF trial.
NEJM Journal Watch — Recent Cardiology Articles- Rosuvastatin Toxicity Observed After Use of Canagliflozin
- Recommended Changes to Critical Congenital Heart Disease Screening by Pulse Oximetry in Newborns
- Air Pollution: No Excuse Not to Exercise
- No Role for Routine Dexmedetomidine in Cardiac Surgery
- Are Radial-Artery Bypass Grafts Better Than Saphenous-Vein Grafts?
-